Skip to content
HowShorted

Ampio Pharmaceuticals Inc. short interest in 2018

In 2018, Ampio Pharmaceuticals Inc.'s disclosed short interest ran from 14.46% of shares outstanding on 12 Jan 2018 to 17.86% on 31 Dec 2018, a change of +3.40 percentage points. The year's high was 19.51% on 31 Jul 2018 and its low 10.19% on 28 Feb 2018, averaging 14.45% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 33.91 days on 13 Jul 2018. Full history: Ampio Pharmaceuticals Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Ampio Pharmaceuticals Inc. in 2018

2018 in figures

Start of year
14.46% (12 Jan 2018)
End of year
17.86% (31 Dec 2018)
Change
+3.40 pp
High
19.51% (31 Jul 2018)
Low
10.19% (28 Feb 2018)
Average
14.45%
Highest days to cover
33.91 (13 Jul 2018)
SEC filings marked
4

Every report in 2018

Ampio Pharmaceuticals Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201814.46%4.42
31 Jan 201814.56%13.38
15 Feb 201814.77%10.81
28 Feb 201810.19%5.48
15 Mar 201810.45%12.3410-K filed
29 Mar 201810.71%9.26
13 Apr 201811.98%6.87
30 Apr 201812.96%15.85
15 May 201813.21%24.0210-Q filed
31 May 201812.34%12.98
15 Jun 201812.44%30.67
29 Jun 201817.39%8.46
13 Jul 201817.66%33.91
31 Jul 201819.51%13.67
15 Aug 201813.36%2.2710-Q filed
31 Aug 201813.33%5.56
14 Sep 201813.48%10.69
28 Sep 201814.31%11.03
15 Oct 201815.27%7.77
31 Oct 201815.27%19.88
15 Nov 201816.08%9.2510-Q filed
30 Nov 201817.14%13.45
14 Dec 201818.05%7.49
31 Dec 201817.86%20.14

See also: Ampio Pharmaceuticals Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.